| Literature DB >> 31838879 |
Brian C Focht1, Alexander R Lucas2, Elizabeth Grainger1, Christina Simpson1, Ciaran M Fairman3, Jennifer M Thomas-Ahner1, Zachary L Chaplow1, Victoria R DeScenza1, Jessica Bowman1, Steven K Clinton1.
Abstract
Objective. To compare the effects of a group-mediated cognitive behavioral (GMCB) exercise and dietary (EX+D) intervention with those of standard-of-care (SC) treatment on select social cognitive outcomes in prostate cancer (PCa) patients undergoing androgen deprivation therapy (ADT). Methods. In the single-blind, 2-arm, randomized controlled Individualized Diet and Exercise Adherence-Pilot (IDEA-P) trial, 32 PCa patients (mean age = 66.2 years; SD = 7.8) undergoing ADT were randomly assigned to a 12-week EX+D intervention (n = 16) or SC treatment (n = 16). The exercise component of the personalized EX+D intervention integrated a combination of supervised resistance and aerobic exercise performed twice per week. The dietary component involved counseling and education to modify dietary intake and composition. Blinded assessments of social cognitive outcomes were obtained at baseline and 2-month and 3-month follow-up. Results. Intent-to-treat analysis of covariance demonstrated that the EX+D intervention resulted in significantly greater improvements in scheduling (P < .05), coping (P < .01), and exercise self-efficacy (P < .05), and satisfaction with function (P < .01) at 3 months relative to SC. Results of partial correlation analysis also demonstrated that select social cognitive outcomes were significantly correlated with primary trial outcomes of mobility performance and exercise participation (P < .05) at 3-month follow-up. Conclusions: The GMCB lifestyle intervention yielded more favorable improvements in relevant social cognitive outcomes relative to SC among PCa patients undergoing ADT. Additionally, more favorable social cognitive outcomes were associated with superior mobility performance and exercise participation following the independent maintenance phase of the EX+D intervention.Entities:
Keywords: oncology; patient-reported outcomes; physical activity; physical function
Mesh:
Substances:
Year: 2019 PMID: 31838879 PMCID: PMC6913059 DOI: 10.1177/1534735419893764
Source DB: PubMed Journal: Integr Cancer Ther ISSN: 1534-7354 Impact factor: 3.077
Select Baseline Patient Characteristics.
| Measure | Intervention Arms, n (%) | |
|---|---|---|
| EX+D | SC | |
| Age, mean (SD) | 69.4 (9.0) | 64.5 (8.6) |
| Ethnicity | ||
| White | 12 (75) | 15 (93.8) |
| African American | 3 (18.8) | 0 (0) |
| Mixed | 0 (0) | 1 (6.2) |
| Not reported | 1 (6.2) | 0 (0) |
| Education | ||
| High school or less | 0 (0) | 0 (0) |
| More than high school | 14 (87.5) | 15 (93.8) |
| Income, US$ | ||
| <$15 000 | 0 (0) | 0 (0) |
| $15 000-35 000 | 1 (6.3) | 2 (12.5) |
| $35 000-50 000 | 3 (18.8) | 1 (6.3) |
| >$50 000 | 11 (68.8) | 12 (75) |
| BMI, kg/m2, mean (SD) | 28.5 (9.05) | 31.5 (6.23) |
| BMI classification | ||
| Underweight | 0 (0) | 0 (0) |
| Normal | 3 (18.8) | 0 (0) |
| Overweight/obese | 12 (75) | 16 (100) |
| Gleason, mean (SD) | 7.77 (1.0) | 7.64 (1.39) |
| Time on ADT (months), mean (SD) | 32.18 (27.28) | 15.31 (19.39) |
| MVPA (minutes), mean (SD) | 59.70 (92.67) | 57.70 (88.14) |
Abbreviations: EX+D, exercise and dietary; SC, standard of care; ADT, androgen deprivation therapy; MVPA, moderate-to-vigorous physical activity.
Figure 1.Consolidated Standards of Reporting Trials (CONSORT) diagram for the Individualized Diet and Exercise Adherence–Pilot (IDEA-P) trial.
Unadjusted Means (SD) for the Social Cognitive Outcomes.
| Variable | Intervention Arms | |
|---|---|---|
| EX+D | SC | |
| Exercise self-efficacy | ||
| Baseline | 81.64 (19.33) | 80.41 (23.81) |
| 2 months | 88.13 (15.43) | 75.47 (33.17) |
| 3 months | 81.33 (24.12) | 63.67 (36.62) |
| Mobility-related self-efficacy | ||
| Baseline | 91.98 (22.59) | 89.79 (14.74) |
| 2 months | 97.40 (5.51) | 94.90 (8.11) |
| 3 months | 96.77 (8.46) | 96.04 (7.38) |
| Task self-efficacy | ||
| Baseline | 7.85 (2.03) | 7.85 (1.97) |
| 2 months | 8.19 (1.84) | 7.90 (1.98) |
| 3 months | 8.27 (1.72) | 7.40 (1.48) |
| Coping self-efficacy | ||
| Baseline | 6.38 (1.86) | 5.67 (2.23) |
| 2 months | 6.56 (2.09) | 5.42 (2.05) |
| 3 months | 7.15 (1.26) | 5.63 (2.18) |
| Scheduling self-efficacy | ||
| Baseline | 7.08 (2.65) | 6.96 (2.32) |
| 2 months | 7.60 (2.11) | 6.77 (2.60) |
| 3 months | 7.83 (2.21) | 6.31 (2.50) |
| Satisfaction with physical function | ||
| Baseline | 1.25 (1.13) | 0.54 (1.53) |
| 2 months | 1.92 (0.55) | 1.03 (1.28) |
| 3 months | 2.04 (0.50) | 0.85 (1.02) |
| Satisfaction with physical appearance | ||
| Baseline | 0.58 (1.31) | −0.48 (1.21) |
| 2 months | 1.25 (1.25) | 0.17 (1.17) |
| 3 months | 1.15 (1.22) | −0.27 (1.14) |
Abbreviations: EX+D, exercise and dietary; SC, standard of care.
Figure 2.Adjusted change in coping self-efficacy.
Figure 3.Adjusted change in scheduling self-efficacy.
Figure 4.Adjusted change in satisfaction with physical function.